Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sruthi Sureshkumar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical and Translational Discovery|August 5, 2024
Targeting autophagy: a promising approach for the treatment of breast cancer brain metastasesSteffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, et al.
Cancer Letters|February 1, 2025
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activityJennifer S Carew, Claudia M Espitia, Sruthi Sureshkumar, et al.
Clinical and Translational Medicine|April 24, 2024
Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinibSteffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, et al.
Cells|July 25, 2025
p47phox: A Central Regulator of NADPH Oxidase Function and a Promising Therapeutic Target in Redox-Related DiseasesMadison E Gamble, Sruthi Sureshkumar, Maria Janina Carrera Espinoza, et al.
Cancers|September 27, 2025
Harnessing p97/VCP: A Transformative AAA+ ATPase Target for Next-Generation Cancer TherapeuticsMaria Janina Carrera Espinoza, Sarah K Tucker, Sruthi Sureshkumar, et al.
Cancer Research Communications|June 5, 2026
p97 Inhibition Synergistically Enhances Hypomethylating Therapy Through Targeting of PLK1 in Acute Myeloid LeukemiaSteffan T Nawrocki, Ning Wang, Claudia M Espitia, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical and Translational Discovery|August 5, 2024
Targeting autophagy: a promising approach for the treatment of breast cancer brain metastasesSteffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, et al.
Cancer Letters|February 1, 2025
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activityJennifer S Carew, Claudia M Espitia, Sruthi Sureshkumar, et al.
Clinical and Translational Medicine|April 24, 2024
Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinibSteffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, et al.
Cells|July 25, 2025
p47phox: A Central Regulator of NADPH Oxidase Function and a Promising Therapeutic Target in Redox-Related DiseasesMadison E Gamble, Sruthi Sureshkumar, Maria Janina Carrera Espinoza, et al.
Cancers|September 27, 2025
Harnessing p97/VCP: A Transformative AAA+ ATPase Target for Next-Generation Cancer TherapeuticsMaria Janina Carrera Espinoza, Sarah K Tucker, Sruthi Sureshkumar, et al.
Cancer Research Communications|June 5, 2026
p97 Inhibition Synergistically Enhances Hypomethylating Therapy Through Targeting of PLK1 in Acute Myeloid LeukemiaSteffan T Nawrocki, Ning Wang, Claudia M Espitia, et al.
Pageof 1